Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1991 Jan;63(1):114–118. doi: 10.1038/bjc.1991.23

Expression of ecto-5'-nucleotidase (CD73) in normal mammary gland and in breast carcinoma.

K H Krüger 1, L F Thompson 1, M Kaufmann 1, P Möller 1
PMCID: PMC1971649  PMID: 1989648

Abstract

Ecto-5'-nucleotidase (ecto-5'-NT) is a phosphatidylinositol anchored membrane structure recently defined as the lymphocyte differentiation antigen CD73. Using CD73 (1E9.28.1) monoclonal antibody, normal mammary gland and breast carcinoma were immunohistochemically investigated for ecto-5'-NT expression. In normal breast epithelium, CD73 was differentially expressed in lobular, ductal and myoepithelial cells and was most frequently detected in the myoepithelial compartment. The glandular stroma contained fibrocytes, a subset of which was also CD73-positive. Among 102 unselected breast carcinoma primary lesions, only 9 contained CD73-positive tumour cells, whereas in 95 cases, stromal fibroblasts and fibrocytes showed variable degrees of CD73 expression. The extent of stromal CD73 expression correlated positively with the estrogen receptor (ER) status of the tumour (P less than 0.038). We conclude that ecto-5'-NT-expression reflects a still unknown state of activity of normal breast epithelium which is lost in the majority of carcinomas derived therefrom. It may also be indicative of some functional activity of stromal fibroblasts which is significantly enhanced in ER-positive carcinomas.

Full text

PDF
114

Images in this article

115Figure 1
on p.115
116Figure 2
on p.116
116Figure 3
on p.116
116Figure 4
on p.116
116Figure 5
on p.116

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrée T., Gutensohn W., Kummer U. Is ecto-5'-nucleotidase essential for stimulation of human lymphocytes? Evidence against a role of the enzyme as mitogenic lectin receptor. Immunobiology. 1987 Sep;175(3):214–225. doi: 10.1016/S0171-2985(87)80030-X. [DOI] [PubMed] [Google Scholar]
  2. BLOOM H. J., RICHARDSON W. W. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer. 1957 Sep;11(3):359–377. doi: 10.1038/bjc.1957.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bailyes E. M., Ferguson M. A., Colaco C. A., Luzio J. P. Inositol is a constituent of detergent-solubilized immunoaffinity-purified rat liver 5'-nucleotidase. Biochem J. 1990 Feb 1;265(3):907–909. doi: 10.1042/bj2650907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bastian J. F., Ruedi J. M., MacPherson G. A., Golembesky H. E., O'Connor R. D., Thompson L. F. Lymphocyte ecto-5'-nucleotidase activity in infancy: increasing activity in peripheral blood B cells precedes their ability to synthesize IgG in vitro. J Immunol. 1984 Apr;132(4):1767–1772. [PubMed] [Google Scholar]
  5. Dickson R. B., McManaway M. E., Lippman M. E. Estrogen-induced factors of breast cancer cells partially replace estrogen to promote tumor growth. Science. 1986 Jun 20;232(4757):1540–1543. doi: 10.1126/science.3715461. [DOI] [PubMed] [Google Scholar]
  6. Dvorak H. F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med. 1986 Dec 25;315(26):1650–1659. doi: 10.1056/NEJM198612253152606. [DOI] [PubMed] [Google Scholar]
  7. Edwards N. L., Gelfand E. W., Burk L., Dosch H. M., Fox I. H. Distribution of 5'-nucleotidase in human lymphoid tissues. Proc Natl Acad Sci U S A. 1979 Jul;76(7):3474–3476. doi: 10.1073/pnas.76.7.3474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Folkman J. Tumor angiogenesis. Adv Cancer Res. 1985;43:175–203. doi: 10.1016/s0065-230x(08)60946-x. [DOI] [PubMed] [Google Scholar]
  9. Hsuan J. J. Transforming growth factors beta. Br Med Bull. 1989 Apr;45(2):425–437. doi: 10.1093/oxfordjournals.bmb.a072332. [DOI] [PubMed] [Google Scholar]
  10. Kao R. T., Hall J., Stern R. Collagen and elastin synthesis in human stroma and breast carcinoma cell lines: modulation by the extracellular matrix. Connect Tissue Res. 1986;14(4):245–255. doi: 10.3109/03008208609017468. [DOI] [PubMed] [Google Scholar]
  11. Knabbe C., Lippman M. E., Wakefield L. M., Flanders K. C., Kasid A., Derynck R., Dickson R. B. Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells. Cell. 1987 Feb 13;48(3):417–428. doi: 10.1016/0092-8674(87)90193-0. [DOI] [PubMed] [Google Scholar]
  12. Kummer U., Mysliwietz J., Gutensohn W., Buschette S., Jahn H., Neuser D., Munker R. Development and properties of a monoclonal antibody specific for human ecto-5'-nucleotidase. Immunobiology. 1984 Mar;166(2):203–211. doi: 10.1016/S0171-2985(84)80038-8. [DOI] [PubMed] [Google Scholar]
  13. Low M. G., Finean J. B. Specific release of plasma membrane enzymes by a phosphatidylinositol-specific phospholipase C. Biochim Biophys Acta. 1978 Apr 20;508(3):565–570. doi: 10.1016/0005-2736(78)90100-1. [DOI] [PubMed] [Google Scholar]
  14. Low M. G. Glycosyl-phosphatidylinositol: a versatile anchor for cell surface proteins. FASEB J. 1989 Mar;3(5):1600–1608. doi: 10.1096/fasebj.3.5.2522071. [DOI] [PubMed] [Google Scholar]
  15. Martinez-Hernandez A. The extracellular matrix and neoplasia. Lab Invest. 1988 Jun;58(6):609–612. [PubMed] [Google Scholar]
  16. Massaia M., Pileri A., Boccadoro M., Bianchi A., Palumbo A., Dianzani U. The generation of alloreactive cytotoxic T lymphocytes requires the expression of ecto-5'nucleotidase activity. J Immunol. 1988 Dec 1;141(11):3768–3775. [PubMed] [Google Scholar]
  17. Naito Y., Lowenstein J. M. 5'-Nucleotidase from rat heart. Biochemistry. 1981 Sep 1;20(18):5188–5194. doi: 10.1021/bi00521a014. [DOI] [PubMed] [Google Scholar]
  18. Raam S., Gelman R., Faulkner J., White G. M., Cohen J. L. Quality control for estrogen receptor quantification by dextran-coated charcoal assay: a single laboratory's experience. Breast Cancer Res Treat. 1982;2(1):111–117. doi: 10.1007/BF01805724. [DOI] [PubMed] [Google Scholar]
  19. Robinson P. J., Millrain M., Antoniou J., Simpson E., Mellor A. L. A glycophospholipid anchor is required for Qa-2-mediated T cell activation. Nature. 1989 Nov 2;342(6245):85–87. doi: 10.1038/342085a0. [DOI] [PubMed] [Google Scholar]
  20. Shah T., Simpson R. J., Webster A. D., Peters T. J. Uptake of free adenosine and adenosine from adenosine monophosphate by human peripheral blood lymphocytes: possible kinetic role for ecto-5'-nucleotidase in the regulation of intracellular adenosine. Clin Exp Immunol. 1986 Oct;66(1):158–165. [PMC free article] [PubMed] [Google Scholar]
  21. Thompson L. F. Ecto-5'-nucleotidase can provide the total purine requirements of mitogen-stimulated human T cells and rapidly dividing human B lymphoblastoid cells. J Immunol. 1985 Jun;134(6):3794–3797. [PubMed] [Google Scholar]
  22. Thompson L. F., Ruedi J. M., Glass A., Low M. G., Lucas A. H. Antibodies to 5'-nucleotidase (CD73), a glycosyl-phosphatidylinositol-anchored protein, cause human peripheral blood T cells to proliferate. J Immunol. 1989 Sep 15;143(6):1815–1821. [PubMed] [Google Scholar]
  23. Thompson L. F., Ruedi J. M., Low M. G. Purification of 5'-nucleotidase from human placenta after release from plasma membranes by phosphatidylinositol-specific phospholipase C. Biochem Biophys Res Commun. 1987 May 29;145(1):118–125. doi: 10.1016/0006-291x(87)91295-2. [DOI] [PubMed] [Google Scholar]
  24. Thompson L. F., Ruedi J. M., O'Connor R. D., Bastian J. F. Ecto-5'-nucleotidase expression during human B cell development. An explanation for the heterogeneity in B lymphocyte ecto-5'-nucleotidase activity in patients with hypogammaglobulinemia. J Immunol. 1986 Oct 15;137(8):2496–2500. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES